Category Specific RSS

Tim Boreham

With their mind blowing medical potential, are hallucinogens the next ASX ‘pot stock’ equivalent?

The mere mention of magic mushrooms, ecstasy or ketamine is enough to send parents of teenagers into conniptions. But are…

5 years ago

Three ASX listed stocks exposed to single party risk

Last week your columnist delved into the issues facing stocks such as Crown Resorts that rely on the stroke of…

5 years ago

The companies that live or die with the stroke of a regulatory pen

Deep in any corporate vault lies a piece of paper or two that affirms the right of an enterprise to…

5 years ago

‘Employee engagement’ emerges as a hot listed sector as workers straggle back to their offices

Most employers would like to think that their workers are champing at the bit to return to more normal conditions…

5 years ago

Coppertunities! How to play the red metal as a serious shortage looms in the Biden era

While investor interest in ‘battery metals’ has focused on lithium and graphite, copper has been the quiet achiever in terms…

6 years ago

How to play the listed Bitcoin game

With Bitcoins – by far the dominant ‘crypto’ – now worth a collective $US1 trillion, massive punts are being made…

6 years ago